[
  {
    "ts": null,
    "headline": "3 medtech takeaways from ESC 2025",
    "summary": "Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.",
    "url": "https://finnhub.io/api/news?id=31d20104570328917761a2b371a276662c3ad5fd1dad36736aa784977cac0e3d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756900800,
      "headline": "3 medtech takeaways from ESC 2025",
      "id": 136616898,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Pulsed field ablation and transcatheter aortic valve implants were in focus at the European Society of Cardiology Congress in Madrid.",
      "url": "https://finnhub.io/api/news?id=31d20104570328917761a2b371a276662c3ad5fd1dad36736aa784977cac0e3d"
    }
  },
  {
    "ts": null,
    "headline": "Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe",
    "summary": "Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”",
    "url": "https://finnhub.io/api/news?id=d7de1f12b6cbef7d84307a90c4c0a25118d8e3b68c9655fd6d65ee8bcd100465",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756896900,
      "headline": "Edwards, Medtronic and Abbott stand to benefit from new TAVR guidelines in Europe",
      "id": 136616929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Analysts said the companies should benefit “as the therapy algorithm is further streamlined and additional patients are encouraged to receive TAVR.”",
      "url": "https://finnhub.io/api/news?id=d7de1f12b6cbef7d84307a90c4c0a25118d8e3b68c9655fd6d65ee8bcd100465"
    }
  },
  {
    "ts": null,
    "headline": "Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment",
    "summary": "Stephan Crokaert, formerly of NeoMedLight, Abbott, Adagio and Boston Scientific, brings more than 35 years of strategic and commercial experience in life sciencesAllegro prepares to advance lead product hydrocelin into clinical trials in 2026 Liege, Belgium – 3 September 2025 (08:30) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, has appointed Stephan Crokaert into the role of Chief Operating Officer as of this month.",
    "url": "https://finnhub.io/api/news?id=69d0083780d812ec107ef9f5ff420f471cbff657bdc8bd4daf6e8c75fb933afa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756884600,
      "headline": "Allegro appoints life sciences veteran as Chief Operating Officer to advance osteoarthritis treatment",
      "id": 136613012,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Stephan Crokaert, formerly of NeoMedLight, Abbott, Adagio and Boston Scientific, brings more than 35 years of strategic and commercial experience in life sciencesAllegro prepares to advance lead product hydrocelin into clinical trials in 2026 Liege, Belgium – 3 September 2025 (08:30) – Allegro NV, a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, has appointed Stephan Crokaert into the role of Chief Operating Officer as of this month.",
      "url": "https://finnhub.io/api/news?id=69d0083780d812ec107ef9f5ff420f471cbff657bdc8bd4daf6e8c75fb933afa"
    }
  }
]